Solel Partners LP: HERBALIFE LTD (HLF): Quarterly 13F Position History
As of Q1 2026, Solel Partners LP reported 1,860,615 shares of HERBALIFE LTD (HLF), worth $27.4M and representing 5.9% of its 13F equity book. The position first appeared in Q1 2021 and has been disclosed across 21 13F-HR filings in Pactolio's tracked window.
- 1,860,615Shares Held (Latest Filing)
- $27.4MReported Market Value (Latest Filing)
- 5.9%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- +$3.4MQuarter-over-Quarter Value Change
- 1,860,615Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 21 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,860,615 | 0 | — | $27.4M | 5.9% | $14.7 |
| Q4 2025 | 1,860,615 | +191,210 | +11.5% | $24.0M | 3.9% | $12.9 |
| Q3 2025 | 1,669,405 | 0 | — | $14.1M | 2.7% | $8.4 |
| Q2 2025 | 1,669,405 | +262,614 | +18.7% | $14.4M | 2.5% | $8.6 |
| Q1 2025 | 1,406,791 | +237,386 | +20.3% | $12.1M | 2.2% | $8.6 |
| Q4 2024 | 1,169,405 | 0 | — | $7.8M | 1.5% | $6.7 |
| Q3 2024 | 1,169,405 | 0 | — | $8.4M | 1.6% | $7.2 |
| Q2 2024 | 1,169,405 | 0 | — | $12.2M | 2.0% | $10.4 |
| Q1 2024 | 1,169,405 | 0 | — | $11.8M | 1.9% | $10.1 |
| Q4 2023 | 1,169,405 | 0 | — | $17.8M | 2.5% | $15.3 |
| Q3 2023 | 1,169,405 | 0 | — | $16.4M | 2.5% | $14.0 |
| Q2 2023 | 1,169,405 | 0 | — | $15.5M | 2.5% | $13.2 |
| Q1 2023 | 1,169,405 | 0 | — | $18.8M | 3.8% | $16.1 |
| Q4 2022 | 1,169,405 | 150,000 | -11.4% | $17.4M | 3.9% | $14.9 |
| Q3 2022 | 1,319,405 | 0 | — | $26.2M | 4.7% | $19.9 |
| Q2 2022 | 1,319,405 | +1,214,405 | +1156.6% | $27.0M | 5.0% | $20.5 |
| Q1 2022 | 105,000 | +105,000 | — | $3.2M | 0.7% | $30.4 |
| Q4 2021 | 0 | 1,000,905 | -100.0% | $0 | 0.0% | — |
| Q3 2021 | 1,000,905 | +205,905 | +25.9% | $42.4M | 8.5% | $42.4 |
| Q2 2021 | 795,000 | +424,600 | +114.6% | $41.9M | 10.1% | $52.7 |
| Q1 2021 | 370,400 | — | — | $16.4M | 4.1% | $44.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Solel Partners LP first disclose a HLF position in 13F-HR filings?
Solel Partners LP first reported HERBALIFE LTD (HLF) on its 13F-HR filing for the period ending 2021-03-31 (Q1 2021). The position has appeared on 21 reported quarters within Pactolio's tracked window.
What was Solel Partners LP's most recent quarter-over-quarter share-count change in HLF?
Solel Partners LP held the same 1,860,615 shares of HLF between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Solel Partners LP's cost basis in HLF?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.